ATE241011T1 - Serin-reiche peptidlinker - Google Patents

Serin-reiche peptidlinker

Info

Publication number
ATE241011T1
ATE241011T1 AT92907232T AT92907232T ATE241011T1 AT E241011 T1 ATE241011 T1 AT E241011T1 AT 92907232 T AT92907232 T AT 92907232T AT 92907232 T AT92907232 T AT 92907232T AT E241011 T1 ATE241011 T1 AT E241011T1
Authority
AT
Austria
Prior art keywords
serine
peptide linkers
ser
rich peptide
domains
Prior art date
Application number
AT92907232T
Other languages
English (en)
Inventor
James S Huston
Hermann Oppermann
Serge N Timasheff
Original Assignee
Micromet Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Micromet Ag filed Critical Micromet Ag
Application granted granted Critical
Publication of ATE241011T1 publication Critical patent/ATE241011T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/705—Fusion polypeptide containing domain for protein-protein interaction containing a protein-A fusion

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT92907232T 1991-02-27 1992-02-27 Serin-reiche peptidlinker ATE241011T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66222691A 1991-02-27 1991-02-27
PCT/US1992/001478 WO1992015682A1 (en) 1991-02-27 1992-02-27 Serine-rich peptide linkers

Publications (1)

Publication Number Publication Date
ATE241011T1 true ATE241011T1 (de) 2003-06-15

Family

ID=24656899

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92907232T ATE241011T1 (de) 1991-02-27 1992-02-27 Serin-reiche peptidlinker

Country Status (9)

Country Link
EP (1) EP0573551B1 (de)
JP (1) JPH06508985A (de)
AT (1) ATE241011T1 (de)
AU (1) AU664030B2 (de)
CA (1) CA2100671C (de)
DE (1) DE69233068T2 (de)
DK (1) DK0573551T3 (de)
ES (1) ES2194838T3 (de)
WO (1) WO1992015682A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7264944B1 (en) 1989-04-21 2007-09-04 Amgen Inc. TNF receptors, TNF binding proteins and DNAs coding for them
DE59010941D1 (de) * 1989-04-21 2005-03-24 Amgen Inc TNF-Rezeptor, TNF bindende Proteine und dafür kodierende DNAs
US6143866A (en) * 1989-07-18 2000-11-07 Amgen, Inc. Tumor necrosis factor (TNF) inhibitor and method for obtaining the same
IL95031A (en) 1989-07-18 2007-03-08 Amgen Inc Method for the production of a human recombinant tumor necrosis factor inhibitor
US6027725A (en) * 1991-11-25 2000-02-22 Enzon, Inc. Multivalent antigen-binding proteins
CA2372813A1 (en) 1992-02-06 1993-08-19 L.L. Houston Biosynthetic binding protein for cancer marker
WO1994012520A1 (en) * 1992-11-20 1994-06-09 Enzon, Inc. Linker for linked fusion polypeptides
US5670347A (en) 1994-05-11 1997-09-23 Amba Biosciences Llc Peptide-mediated gene transfer
TW555765B (en) 1996-07-09 2003-10-01 Amgen Inc Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
CN1242062C (zh) * 1998-07-10 2006-02-15 赛欧斯公司 生产等电点高于8或低于5的多肽的方法
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
US9321832B2 (en) 2002-06-28 2016-04-26 Domantis Limited Ligand
DK1691833T3 (da) 2003-11-28 2010-05-03 Micromet Ag Præparater der omfatter polypeptider
US7235641B2 (en) 2003-12-22 2007-06-26 Micromet Ag Bispecific antibodies
WO2008028686A2 (en) 2006-09-10 2008-03-13 Glycotope Gmbh Use of human cells of myeloid leukaemia origin for expression of antibodies
PL1920781T3 (pl) 2006-11-10 2015-06-30 Glycotope Gmbh Kompozycje zawierające core-1-dodatnie mikroorganizmy i ich zastosowanie w leczeniu lub profilaktyce nowotworów
EP2085095B1 (de) 2008-01-17 2012-03-07 Philogen S.p.A. Kombination aus einem Anti-EDb-Fibronectin-Antikörper-IL-2-Fusionsprotein und einem B-Zellen bindenden Molekül, B-Zellen-Vorläufern und/oder deren krebserregendem Gegenspieler
EP2116555A1 (de) 2008-05-08 2009-11-11 Bayer Schering Pharma Aktiengesellschaft Verwendung eines spezifisch an ED-B Fibronectin bindenden radioaktiv markierten Moleküls bei einem Verfahren zur Behandlung von Hodgkin-Lymphom
CN102282168A (zh) 2008-11-18 2011-12-14 梅里麦克制药股份有限公司 人血清白蛋白接头以及其结合物
WO2011110490A1 (en) 2010-03-09 2011-09-15 Bayer Pharma Aktiengesellschaft Process for the production of radioactively labelled scfv antibody fragments, kits and compositions
CN103384681B (zh) 2010-12-23 2018-05-18 霍夫曼-拉罗奇有限公司 结合剂
CA2817455C (en) * 2010-12-23 2019-04-16 F. Hoffmann-La Roche Ag Detection of a polypeptide dimer by a bivalent binding agent
EP2655413B1 (de) 2010-12-23 2019-01-16 F.Hoffmann-La Roche Ag Polypeptid-polynukleotid-komplex und verwendung bei der gezielten effektorrest-bereitstellung
EP2659269B1 (de) 2010-12-23 2016-10-26 Roche Diagniostics GmbH Erkennung von posttranslational modifiziertem polypeptid durch ein bivalentes bindungsmolekül
EP2748302B1 (de) 2011-08-22 2018-08-15 Glycotope GmbH Mikroorganismen mit einem tumor-antigen
JP6126097B2 (ja) * 2011-09-06 2017-05-10 ノヴォ ノルディスク アー/エス Glp−1誘導体
US20130344565A1 (en) * 2012-06-21 2013-12-26 Rapid Pathogen Screening, Inc. Optimization of Expression and Purification of Recombinant Human MxA Protein in E. Coli
US9345766B2 (en) 2012-08-30 2016-05-24 Merrimack Pharmaceuticals, Inc. Combination therapies comprising anti-ERBB3 agents
SG11201705988UA (en) 2015-02-24 2017-08-30 Bioatla Llc Conditionally active biological proteins
CA3003399A1 (en) 2015-11-02 2017-05-11 Bioatla, Llc Conditionally active polypeptides
EP3794042B1 (de) 2018-05-18 2024-03-27 Daiichi Sankyo Co., Ltd. Conjugue agent cytotoxique et anticorps anti-muc1-exatecan
WO2020144164A1 (en) 2019-01-07 2020-07-16 Bactolife Aps Pathogen binding proteins
PH12022550165A1 (en) 2019-07-26 2023-05-08 Visterra Inc Interleukin-2 agents and uses thereof
CA3203977A1 (en) 2020-12-04 2022-06-09 Visterra, Inc. Methods of using interleukin-2 agents
TW202333772A (zh) 2021-12-01 2023-09-01 美商威特拉公司 使用介白素-2藥劑之方法
WO2024261239A1 (en) 2023-06-23 2024-12-26 Imcheck Therapeutics Bispecific antibodies targeting btn3a and the pd-1/pd-l1 inhibitory axis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US831967A (en) * 1905-08-29 1906-09-25 Eugenie Mearis Table.
EP0489116B1 (de) * 1989-08-22 1994-04-06 Immunex Corporation Fusionsprotein bestehend aus gm-csf und il-3
CA2372813A1 (en) * 1992-02-06 1993-08-19 L.L. Houston Biosynthetic binding protein for cancer marker

Also Published As

Publication number Publication date
JPH06508985A (ja) 1994-10-13
AU1440392A (en) 1992-10-06
DE69233068T2 (de) 2004-01-22
CA2100671A1 (en) 1992-08-28
CA2100671C (en) 1999-02-02
WO1992015682A1 (en) 1992-09-17
ES2194838T3 (es) 2003-12-01
DE69233068D1 (de) 2003-06-26
AU664030B2 (en) 1995-11-02
EP0573551A4 (en) 1994-06-08
DK0573551T3 (da) 2003-08-04
EP0573551A1 (de) 1993-12-15
EP0573551B1 (de) 2003-05-21

Similar Documents

Publication Publication Date Title
DE69233068D1 (de) Serin-reiche peptidlinker
BR9812267B1 (pt) Hormônio de crescimento recombinante.
ES2176286T3 (es) Esteres de metido de pentapeptidos inhibidoras del cancer de seres humanos.
ATE338771T1 (de) Antagonisten des intestinotrophen glp-2 peptides
HU9501276D0 (en) Stabile, liophylised composition containing proteins
ATE154641T1 (de) Neues physiologisch aktives schweinepeptid (cnp- 53)
ES2084621T3 (es) Proteina biologicamente activa modificada.
ES2058479T3 (es) Compuestos peptidicos.
DK0478631T3 (da) Målsøgende midler
NO902871L (no) Fremgangsmaate for innfoering av et peptid i cytosol.
DK1040191T3 (da) RANTES-mutanter og terapeutiske anvendelser heraf
ES2087337T3 (es) Composiciones de implantes que contienen una proteina, peptido o polipeptido biologicamente activos.
NZ231636A (en) Anticoagulant peptides analogus to hirudins' active site
DE69002881D1 (de) Peptide und deren Benutzung.
DE59108261D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
GB2352518B (en) Screening of compunds for therapeutic activity
MX9205978A (es) Nuevas proteinas inhibidoras de trombina de garrapatas.
SE9101586D0 (sv) Modified thioredoxin and its use
DE3869939D1 (de) Biologisch wirksame peptide.
DE68901361D1 (de) Anorexigenische und hypotensive peptide.
KR920700224A (ko) 신규의 생리활성 펩티드 및 이를 유효성분으로서 함유한 칼슘대사 조절제
GB8924416D0 (en) Sliding"pucker reducing"presser foot

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0573551

Country of ref document: EP